HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sreenivas Nannapaneni Selected Research

Head and Neck Neoplasms (Head and Neck Cancer)

1/2021Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth in vivo in head and neck cancer models.
11/2020Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck.
12/2017Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
1/2016Antitumor Activity of 2,9-Di-Sec-Butyl-1,10-Phenanthroline.
3/2014Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.
1/2014Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.
3/2013Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.
8/2012A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.
7/2012Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sreenivas Nannapaneni Research Topics

Disease

19Neoplasms (Cancer)
11/2021 - 05/2012
15Squamous Cell Carcinoma of Head and Neck
11/2021 - 05/2012
9Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 07/2012
4Lung Neoplasms (Lung Cancer)
08/2017 - 08/2012
2Neoplasm Metastasis (Metastasis)
01/2020 - 09/2012
2Lymphatic Metastasis
09/2012 - 07/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2017
1Oral Leukoplakia
03/2014
1Carcinoma in Situ
03/2014
1Exanthema (Rash)
03/2014
1Carcinogenesis
03/2014

Drug/Important Bio-Agent (IBA)

5Small Interfering RNA (siRNA)IBA
01/2020 - 05/2012
4Cetuximab (Erbitux)FDA Link
11/2021 - 08/2012
3Biomarkers (Surrogate Marker)IBA
11/2020 - 07/2012
3ErbB Receptors (EGF Receptor)IBA
03/2014 - 08/2012
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2016
2IntegrinsIBA
01/2020 - 09/2012
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 12/2017
2honokiolIBA
01/2018 - 01/2014
2seribantumabIBA
02/2017 - 07/2014
2Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2014 - 03/2013
2Celecoxib (Celebrex)FDA Link
03/2014 - 03/2013
1tipifarnib (R115777)IBA
11/2021
1Farnesyltranstransferase (Farnesyltransferase)IBA
11/2021
1Annexin A5IBA
11/2021
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2021
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
01/2021
1cabozantinibIBA
01/2021
1ARQ 197IBA
01/2021
1TeaIBA
01/2021
1AfatinibIBA
01/2021
1CrizotinibIBA
01/2021
1ResveratrolIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
09/2019
1SurvivinIBA
01/2018
1AZD 6244IBA
08/2017
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2017
1Therapeutic UsesIBA
08/2017
1Phenformin (Fenformin)IBA
08/2017
12,9-di-sec-butyl-1,10-phenanthrolineIBA
01/2016
1Cisplatin (Platino)FDA LinkGeneric
01/2016
1Messenger RNA (mRNA)IBA
01/2016
1LigandsIBA
01/2016
1Monoclonal AntibodiesIBA
07/2014
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2014
1Paclitaxel (Taxol)FDA LinkGeneric
01/2014
1LuteolinIBA
01/2014
1PolymersIBA
01/2014
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
07/2013
1EnzymesIBA
03/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2013
1matrigelIBA
09/2012
1Bevacizumab (Avastin)FDA Link
08/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012
1Immunoglobulin G (IgG)IBA
08/2012
1Aldehyde DehydrogenaseIBA
07/2012
1Aldehyde Dehydrogenase 1 FamilyIBA
07/2012

Therapy/Procedure

7Therapeutics
12/2017 - 05/2012
5Chemoprevention
01/2021 - 03/2013
1Drug Therapy (Chemotherapy)
01/2014
1Quantum Dots (Quantum Dot)
07/2012
1Intravenous Injections
05/2012